Abstract
Session presented on:Tuesday, July 23, 2013:
Purpose: To communicate psychometric properties of the new 0-5 Halpin Nausea and Vomiting (HNV) scales with descriptors, so learners can use scales in clinical practice.
Methods: A methodological design was applied to establish psychometrics of HNV scales using three groups of patients, N = 163. Group I was admitted with a diagnosis of NV, n=54. Group II consisted of cancer patients scheduled for chemotherapy, n=52. Group III was a control group with medical-surgical diagnoses and no expected NV, n=57.
Results: HNV scales had a high inter-rater reliability (Kappa test=.851, p<.001). Concurrent validity was established between the HNV scales and Morrow's worst nausea ratings, significant'(r=.318, p=.03). HNV was found to measure fine differences between and within groups, establishing sensitivity. Chi square tests were non-significant for ethnicity, gender, coronary artery disease, hypertension, diabetes, congestive heart failure, other medical surgical diagnosis and risk for PONV. Group I had more nausea patients (X2=63.94, p<.001) and higher degree of the diagnosis of pancreatitis (X2=8.72, p=.01). Group II had more cancer (X2=76.00, p<.001), and chemo patients (X2=93.06, p<.001). In terms of age, one way analysis of variance indicated that the groups are significantly different (F=6.12, p=.003). Scheffe's test indicates that group I (the NV group) were significantly younger (p<.05) than the control and the cancer group. Group II and III were homogenous with no significantly difference in age.
Conclusion: Accurate assessment of NV with valid and reliable scales can lead to more accurate and timely treatment. Alleviation of patient's discomfort is improved by scales with descriptors because the specific patient response has an individual measurement. Patients can rank and use the descriptors to communicate their symptom severity. Knowing the intensity of NV predictors in surgical and chemotherapy patients supports use of HNV scales to promote symptom management and improves quality of life.
Sigma Membership
Gamma Tau at-Large
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Nausea, Vomiting, Psychometrics
Recommended Citation
Halpin, Angela P. and Huckabay, Loucine M., "Psychometrics of Halpin Nausea and Vomiting Scales for use in clinical practice" (2013). INRC (Congress). 183.
https://www.sigmarepository.org/inrc/2013/presentations_2013/183
Conference Name
24th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Prague, Czech Republic
Conference Year
2013
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Psychometrics of Halpin Nausea and Vomiting Scales for use in clinical practice
Prague, Czech Republic
Session presented on:Tuesday, July 23, 2013:
Purpose: To communicate psychometric properties of the new 0-5 Halpin Nausea and Vomiting (HNV) scales with descriptors, so learners can use scales in clinical practice.
Methods: A methodological design was applied to establish psychometrics of HNV scales using three groups of patients, N = 163. Group I was admitted with a diagnosis of NV, n=54. Group II consisted of cancer patients scheduled for chemotherapy, n=52. Group III was a control group with medical-surgical diagnoses and no expected NV, n=57.
Results: HNV scales had a high inter-rater reliability (Kappa test=.851, p<.001). Concurrent validity was established between the HNV scales and Morrow's worst nausea ratings, significant'(r=.318, p=.03). HNV was found to measure fine differences between and within groups, establishing sensitivity. Chi square tests were non-significant for ethnicity, gender, coronary artery disease, hypertension, diabetes, congestive heart failure, other medical surgical diagnosis and risk for PONV. Group I had more nausea patients (X2=63.94, p<.001) and higher degree of the diagnosis of pancreatitis (X2=8.72, p=.01). Group II had more cancer (X2=76.00, p<.001), and chemo patients (X2=93.06, p<.001). In terms of age, one way analysis of variance indicated that the groups are significantly different (F=6.12, p=.003). Scheffe's test indicates that group I (the NV group) were significantly younger (p<.05) than the control and the cancer group. Group II and III were homogenous with no significantly difference in age.
Conclusion: Accurate assessment of NV with valid and reliable scales can lead to more accurate and timely treatment. Alleviation of patient's discomfort is improved by scales with descriptors because the specific patient response has an individual measurement. Patients can rank and use the descriptors to communicate their symptom severity. Knowing the intensity of NV predictors in surgical and chemotherapy patients supports use of HNV scales to promote symptom management and improves quality of life.